Premature ovarian failure and FMR1 gene mutations: An update;Insuffisance ovarienne prématurée et mutations du gène FMR1: Avancées récentes

Annales d'Endocrinologie

Volumn 71, Issue 3, 2010, Pages 215-217

  Conway, G S ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Fragile X premutations; FRAXA premutation; Premature ovarian failure

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ARTICLE; DISEASE ASSOCIATION; FAMILY; FRAGILE X SYNDROME; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; INHERITANCE; OVARY FUNCTION; PEDIGREE ANALYSIS; PREMATURE OVARIAN FAILURE; RISK; TRINUCLEOTIDE REPEAT;

FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENETIC TESTING; HUMANS; MALE; MUTATION; OVARIAN FAILURE, PREMATURE; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 77952742678     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2010.02.009     Document Type: Article

References (25)

1. Conway G.S., Hettiarachchi S., Murray A., Jacobs P.A. Fragile X premutations in familial premature ovarian failure. Lancet 1995, 346:309-310.
2. Oostra B.A., Willemsen R. FMR1: a gene with three faces. Biochim Biophys Acta 2009, 1790:467-477.
3. Chonchaiya W., Schneider A., Hagerman R.J. Fragile X: a family of disorders. Adv Pediatr 2009, 56:165-186.
4. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am J Med Genet 1996, 64:196-197.
5. Garber K.B., Visootsak J., Warren S.T. Fragile X syndrome. Eur J Hum Genet 2008, 16:666-672.
6. Bourgeois J.A., Coffey S.M., Rivera S.M., Hessl D., Gane L.W., Tassone F., et al. A review of fragile X premutation disorders: expanding the psychiatric perspective. J Clin Psychiatry 2009, 70:852-862.
7. Brouwer J.R., Willemsen R., Oostra B.A. The FMR1 gene and fragile X-associated tremor/ataxia syndrome. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:782-798.
8. Cornish K., Turk J., Hagerman R. The fragile X continuum: new advances and perspectives. J Intellect Disabil Res 2008, 52:469-482.
9. Bachner D., Manca A., Steinbach P., Wohrle D., Just W., Vogel W., et al. Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad. Hum Mol Genet 1993, 2:2043-2050.
10. Conway G.S., Payne N.N., Webb J., Murray A., Jacobs P.A. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998, 13:1184-1187.
11. Vianna-Morgante A.M., Costa S.S., Pares A.S., Verreschi I.T. FRAXA premutation associated with premature ovarian failure. Am J Med Genet 1996, 64:373-375.
12. Marozzi A., Vegetti W., Manfredini E., Tibiletti M.G., Testa G., Crosignani P.G., et al. Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 2000, 15:197-202.
13. Machado-Ferreira Mdo C., Costa-Lima M.A., Boy R.T., Esteves G.S., Pimentel M.M. Premature ovarian failure and FRAXA premutation: positive correlation in a Brazilian survey. Am J Med Genet A 2004, 126A:237-240.
14. Gersak K., Meden-Vrtovec H., Peterlin B. Fragile X premutation in women with sporadic premature ovarian failure in Slovenia. Hum Reprod 2003, 18:1637-1640.
15. Goswami D., Conway G.S. Premature ovarian failure. Hum Reprod Update 2005, 11:391-410.
16. Miano M.G., Laperuta C., Chiurazzi P., D'Urso M., Ursini M.V. Ovarian dysfunction and FMR1 alleles in a large Italian family with POF and FRAXA disorders: case report. BMC Med Genet 2007, 8:18.
17. Corrigan E.C., Raygada M.J., Vanderhoof V.H., Nelson L.M. A woman with spontaneous premature ovarian failure gives birth to a child with fragile X syndrome. Fertil Steril 2005, 84:1508.
18. Fryns J.P. Ovarian function in fragile X carriers. Genet Couns 1996, 7:245-247.
19. Murray A., Webb J., MacSwiney F., Shipley E.L., Morton N.E., Conway G.S. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod 1999, 14:1217-1218.
20. Rohr J., Allen E.G., Charen K., Giles J., He W., Dominguez C., et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod 2008, 23:1220-1225.
21. Welt C.K., Smith P.C., Taylor A.E. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004, 89(9):4569-4574.
22. Murray A., Ennis S., MacSwiney F., Webb J., Morton N.E. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet 2000, 8:247-252.
23. Murray A., Ennis S., Morton N. No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers. Am J Hum Genet 2000, 67:253-254.
24. Spath M.A., Nillesen W.N., Smits A.P., Feuth T.B., Braat D.D., van Kessel A.G., et al. X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers. Am J Med Genet A 2010, 152A:387-393.
25. Pembrey M.E., Barnicoat A.J., Carmichael B., Bobrow M., Turner G. An assessment of screening strategies for fragile X syndrome in the UK. Health Technol Assess 2001, 5:1-95.